Common Skin Reactions to Cosentyx
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis and other conditions, often causes skin issues at the injection site. These include redness, itching, pain, swelling, bruising, bleeding, or warmth, affecting up to 19% of patients.[1][2] Reactions are usually mild and resolve within days, but monitor for infection signs like pus or fever.
Serious Skin Risks and Infections
Rare but severe risks include inflammatory bowel disease flares with skin involvement or new psoriasis onset (potentially pustular type), reported in <1% of cases.[1] It increases susceptibility to skin infections like cellulitis, herpes infections, or fungal issues (e.g., tinea), due to immune suppression—occurring in 1-3% of users.[2][3] Allergic reactions like rash, hives, or angioedema can escalate to anaphylaxis in very rare instances.[1]
How Long Do Skin Side Effects Last?
Injection-site reactions peak within hours and fade in 1-14 days for most.[2] Persistent or worsening symptoms warrant medical review, as they may signal infection or hypersensitivity.
Who Gets Skin Risks Most?
Higher rates occur in psoriasis patients (up to 22% injection reactions) versus psoriatic arthritis users (around 10%).[3] Risk rises with prior skin conditions or concurrent immunosuppressants; children and elderly show similar profiles but less data.[1]
Managing and Preventing Skin Issues
Rotate injection sites (thigh, abdomen, upper arm), use proper technique, and apply cold packs post-injection.[2] Report severe reactions immediately—discontinuation resolves most cases. No routine premedication is standard, but antihistamines help mild itching.
[1] Cosentyx Prescribing Information, Novartis, 2023. https://www.cosentyx.com
[2] FDA Label for Secukinumab, 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125504s042lbl.pdf
[3] ClinicalTrials.gov summaries (e.g., NCT01695239), analyzed via Drugs.com side effects database. https://www.drugs.com/sfx/cosentyx-side-effects.html